摘要:
A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by formula (I) wherein R - R4 are as defined herein, or a pharmaceutically-acceptable salt thereof.
摘要:
A class of compounds is described which can be used for the treatment of viral infections. Compounds of particular interest are defined by Formula (II) wherein each of R?1, R2, and R3¿ is independently selected from hydrido, halo, and nitro; wherein R8 is selected from haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted arylalkoxy and optionally substituted aryloxyalkyl; wherein Y is selected from fluoroalkyl, and (A); and wherein (R9) is alkylamino; or a pharmaceutically-acceptable salt or tautomer thereof.
摘要:
A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by formula (I) wherein R - R4 are as defined herein, or a pharmaceutically-acceptable salt thereof.
摘要:
A class of compounds is described which can be used for the treatment of viral infections. Compounds of particular interest are defined by Formula (II) wherein each of R?1, R2, and R3¿ is independently selected from hydrido, halo, and nitro; wherein R8 is selected from haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted arylalkoxy and optionally substituted aryloxyalkyl; wherein Y is selected from fluoroalkyl, and (A); and wherein (R9) is alkylamino; or a pharmaceutically-acceptable salt or tautomer thereof.
摘要:
This invention relates to compounds having formula (I) or a pharmaceutically acceptable salt thereof which are useful in the inhibition of platelet aggregation, to pharmaceutical compositions of such phenylamidines derivatives, and to a method of inhibiting platelet aggregation in mammals by administering such compounds and compositions.